These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 21414905)

  • 1. Neural correlates of an injury-free model of central sensitization induced by opioid withdrawal in humans.
    Wanigasekera V; Lee MC; Rogers R; Hu P; Tracey I
    J Neurosci; 2011 Feb; 31(8):2835-42. PubMed ID: 21414905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative pain management in the opioid-tolerant individual.
    Gordon D; Inturrisi CE; Greensmith JE; Brennan TJ; Goble L; Kerns RD
    J Pain; 2008 May; 9(5):383-7. PubMed ID: 18337186
    [No Abstract]   [Full Text] [Related]  

  • 3. Opioid-induced hyperalgesia in clinical anesthesia practice: what has remained from theoretical concepts and experimental studies?
    Weber L; Yeomans DC; Tzabazis A
    Curr Opin Anaesthesiol; 2017 Aug; 30(4):458-465. PubMed ID: 28590258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
    Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
    Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endogenous opioid system is not involved in modulation of opioid-induced hyperalgesia.
    Chu LF; Dairmont J; Zamora AK; Young CA; Angst MS
    J Pain; 2011 Jan; 12(1):108-15. PubMed ID: 20864417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remifentanil-induced tolerance, withdrawal or hyperalgesia in infants: a randomized controlled trial. RAPIP trial: remifentanil-based analgesia and sedation of paediatric intensive care patients.
    Welzing L; Link F; Junghaenel S; Oberthuer A; Harnischmacher U; Stuetzer H; Roth B
    Neonatology; 2013; 104(1):34-41. PubMed ID: 23635551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal.
    Angst MS; Koppert W; Pahl I; Clark DJ; Schmelz M
    Pain; 2003 Nov; 106(1-2):49-57. PubMed ID: 14581110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of opioid-induced hyperalgesia.
    Lee M; Silverman SM; Hansen H; Patel VB; Manchikanti L
    Pain Physician; 2011; 14(2):145-61. PubMed ID: 21412369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid-Induced Hyperalgesia in the Nonsurgical Setting: A Systematic Review.
    Yang DZ; Sin B; Beckhusen J; Xia D; Khaimova R; Iliev I
    Am J Ther; 2019; 26(3):e397-e405. PubMed ID: 29726847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of synaptic long-term potentiation after opioid withdrawal.
    Drdla R; Gassner M; Gingl E; Sandkühler J
    Science; 2009 Jul; 325(5937):207-10. PubMed ID: 19590003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ginsenosides on opioid-induced hyperalgesia in mice.
    Li P; Tang M; Li H; Huang X; Chen L; Zhai H
    Neuroreport; 2014 Jul; 25(10):749-52. PubMed ID: 24709919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon?
    Eisenberg E; Suzan E; Pud D
    J Pain Symptom Manage; 2015 Mar; 49(3):632-6. PubMed ID: 25128284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder.
    Shi Z; Jagannathan K; Padley JH; Wang AL; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    Addict Biol; 2021 Jul; 26(4):e12977. PubMed ID: 33098179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroacupuncture Treatment Alleviates the Remifentanil-Induced Hyperalgesia by Regulating the Activities of the Ventral Posterior Lateral Nucleus of the Thalamus Neurons in Rats.
    Zhao HY; Liu LY; Cai J; Cui YJ; Xing GG
    Neural Plast; 2018; 2018():6109723. PubMed ID: 30534151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioid Induced Hyperalgesia.
    Yi P; Pryzbylkowski P
    Pain Med; 2015 Oct; 16 Suppl 1():S32-6. PubMed ID: 26461074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for the development of acute analgesic tolerance during and hyperalgesia after prolonged remifentanil administration in mice.
    Ishii H; Petrenko AB; Kohno T; Baba H
    Mol Pain; 2013 Mar; 9():11. PubMed ID: 23497285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gabapentin in preventing fentanyl- and morphine-withdrawal-induced hyperalgesia in rats.
    Wei X; Wei W
    J Anesth; 2012 Apr; 26(2):236-41. PubMed ID: 22048285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Descending facilitatory pathways from the rostroventromedial medulla mediate naloxone-precipitated withdrawal in morphine-dependent rats.
    Vera-Portocarrero LP; Ossipov MH; Lai J; King T; Porreca F
    J Pain; 2011 Jun; 12(6):667-76. PubMed ID: 21354865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic deletion of microglial Panx1 attenuates morphine withdrawal, but not analgesic tolerance or hyperalgesia in mice.
    Burma NE; Leduc-Pessah H; Trang T
    Channels (Austin); 2017 Sep; 11(5):487-494. PubMed ID: 28745932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.